Means Investment CO. Inc. Lowers Holdings in iShares Biotechnology ETF $IBB

Means Investment CO. Inc. decreased its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 29.4% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 6,583 shares of the financial services provider’s stock after selling 2,740 shares during the period. Means Investment CO. Inc.’s holdings in iShares Biotechnology ETF were worth $833,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in the business. Brighton Jones LLC purchased a new position in iShares Biotechnology ETF in the 4th quarter worth approximately $201,000. CX Institutional bought a new stake in shares of iShares Biotechnology ETF during the first quarter valued at approximately $32,000. BigSur Wealth Management LLC raised its position in shares of iShares Biotechnology ETF by 32.6% during the first quarter. BigSur Wealth Management LLC now owns 8,250 shares of the financial services provider’s stock valued at $1,055,000 after buying an additional 2,030 shares during the last quarter. Rye Brook Capital LLC lifted its holdings in shares of iShares Biotechnology ETF by 0.9% in the first quarter. Rye Brook Capital LLC now owns 21,500 shares of the financial services provider’s stock worth $2,750,000 after buying an additional 200 shares in the last quarter. Finally, Wealth Enhancement Advisory Services LLC lifted its holdings in shares of iShares Biotechnology ETF by 2.8% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 41,921 shares of the financial services provider’s stock worth $5,362,000 after buying an additional 1,160 shares in the last quarter. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 1.4%

IBB opened at $149.95 on Friday. The company has a fifty day moving average of $140.94 and a 200 day moving average of $130.59. iShares Biotechnology ETF has a fifty-two week low of $107.43 and a fifty-two week high of $153.01.

iShares Biotechnology ETF Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, September 19th. Stockholders of record on Tuesday, September 16th were given a dividend of $0.0828 per share. The ex-dividend date was Tuesday, September 16th. This represents a $0.33 dividend on an annualized basis and a dividend yield of 0.2%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.